An antigen-driven B-cell response within the salivary glands of patients with Sjögren’s syndrome by Stott, D.I. & Berek, C.
 
 
 
 
 
 
Stott, D.I. and Berek, C. (2002) An antigen-driven B-cell response within 
the salivary glands of patients with Sjögren’s syndrome. Annals of the 
Marie Curie Fellowship Association 2:pp. 108-116.
 
 
 
 
 
 
 
 
http://eprints.gla.ac.uk/3598/ 
 
 
 
 
Glasgow ePrints Service 
http://eprints.gla.ac.uk 
AN ANTIGEN-DRIVEN B-CELL RESPONSE WITHIN THE 
SALIVARY GLANDS OF PATIENTS WITH SJÖGREN’S 
SYNDROME 
 
David I. Stott* and Claudia Berek† 
 
*Marie Curie Fellow, Dept. of Immunology, University of Glasgow, Western 
Infirmary, Glasgow G11 6NT, Scotland, U.K., email: d.i.stott@clinmed.gla.ac.uk; 
†Deutsches Rheumaforschungszentrum, Schumannstrasse 21/22, D-10117 Berlin 
Germany. 
 
 
ABSTRACT 
 
Infection with a bacterium or virus induces the production of antibodies, specialised protein molecules 
that bind to and eliminate the microorganism.  These antibodies are produced by B-cells that are 
stimulated by antigen (any foreign protein or carbohydrate) in the lymph nodes and spleen.  During 
this process,  they  diversify their variable region genes (V-genes), encoding the antigen-binding 
region of the antibody, by switching on machinery that mutates the V-genes at a very high rate 
(somatic hypermutation).  In autoimmune diseases, B-cells produce autoantibodies against self-
antigens present on the patient’s own tissues.  Clusters of B- and T-cells are frequently found in the 
target organs of autoimmune diseases.  The aim of the work described here was to determine whether 
these clusters of cells are responding to stimulation by antigen.  For this purpose we investigated the B-
cell response in patients with an autoimmune disease affecting the salivary and lachrymal glands.  By 
cloning and sequencing the expressed V-genes from individual clusters of cells in the salivary glands, 
we were able to show that the B-cells in these clusters are undergoing clonal proliferation, somatic 
hypermutation and antigen selection.  The presence of similar structures in the target tissues of other 
autoimmune diseases suggests that this is a widespread phenomenon. 
 
Keywords: Sjögren’s syndrome; Germinal centre; Somatic hypermutation; V-gene; 
Autoimmune disease. 
 
 
1. INTRODUCTION 
 
In order to protect the body against infection by 
pathogenic microorganisms, the immune system 
employs two specific means of defence: 
cytotoxic T-cells are able to recognise and kill 
virus infected host cells; B-cells respond by 
producing antibodies, protein molecules which 
bind specifically to their target and eliminate 
bacteria, viruses or other pathogens from the 
body.  Antibodies that specifically recognise any 
protein, carbohydrate or other organic molecule 
can be produced by the immune system, which 
has developed a unique system for generating an 
enormous diversity of antibody molecules.  This 
diversity is generated at two distinct stages of B-
cell development.  The first stage occurs  during 
the development of a virgin B-cell, i.e. one that 
has not yet encountered antigen, from a stem 
cell.     A large number of different antibodies 
are generated by variable recombination of the 
heavy and light chain gene segments (V, D & J) 
making up the antigen-binding site of the 
antibody (immunoglobulin) molecule, (Fig. 1).  
Diversity is increased further by variation in the 
exact position of joining and random addition of 
untemplated nucleotides at the junctions.  Each 
B-cell produces only one antibody, but many B-
cells are generated, each producing antibody 
with a different antigen-binding site.  The 
second stage occurs after the B-cell has been 
stimulated by binding of antigen to antibody 
molecules on its surface.  The B-cell starts to 
divide and differentiate in clusters of cells 
(germinal centres) in the lymph nodes and 
spleen.  At the same time, the rearranged V-
genes start to mutate at a very high rate, 
generating further diversity.  Mutations 
accumulate, especially in the complementarity 
regions (CDRs), which make contact with the 
antigen.  B-cells with mutated receptors compete 
for binding to antigen on the surface of 
follicular dendritic cells (FDCs) within the 
germinal centre.  B-cells which express antigen 
receptors with high affinity are selected to 
differentiate into antibody-secreting plasma cells 
and leave the germinal centre[1-3].   
 
Sjögren's syndrome (SS) patients 
develop chronic inflammatory lesions in the 
salivary and lachrymal glands with degeneration 
of the glandular tissue and severely diminished 
secretion.  This can cause infection of the eyes 
and mouth and these patients also have an 
increased incidence of B-cell lymphoma.  
Primary SS is not associated with other 
autoimmune diseases, whereas secondary SS is 
found in patients with systemic lupus 
erythematosus (SLE), rheumatoid arthritis and 
other autoimmune diseases.  Approximately 
25% of SS patients also have rheumatoid 
arthritis[8].  The major autoantibodies 
associated with SS recognise IgG (rheumatoid 
factor (RF)), protein antigens associated with 
RNA (Ro and La), salivary duct antigens [10] 
and α-fodrin.  Several of these autoantibodies 
appear to have pathogenic activity, including 
antibodies against α-fodrin [11].  Anti-Ro and 
anti-La are believed to cause congenital heart 
block in the children of mothers with Sjögren's 
syndrome, due to transplacental passage of the 
antibodies which bind to fetal heart muscle 
[12;12-14].    Infiltrating B- and T-cells are 
found in the salivary, lachrymal glands, the 
respiratory tract, gastrointestinal tract and 
vagina.  Clusters of B- and T-cells and 
numerous plasma cells, are found in the salivary 
glands of SS patients [8;9], which have been 
shown to secrete autoantibodies, including 
rheumatoid factor, anti-Ro and anti-La 
[8;15;16].  We have examined Ig V-gene 
expression by B-cells in these lymphoid cell 
clusters in order to determine whether the B-
cells are undergoing antigen-driven clonal 
proliferation, somatic hypermutation and affinity 
selection in situ, or whether they migrate 
independently into the target tissue after antigen 
stimulation in the secondary lymphoid organs. 
 
 
 
 
Figure 1.  Diagrammatic representation of the 
rearrangement of immunoglobulin heavy and 
light chain gene segments during the 
differentiation of a stem cell to a virgin B-cell;  
(a) Vκ-gene rearrangement; (b) VH-gene 
rearrangement.  The coding sequences (exons) 
are represented by boxes and non-coding 
sequences (introns) are represented by lines.  
Exons are chosen at random and additional 
bases, not encoded in the DNA, are added at the 
junctions.  This results in expression of a unique 
antigen receptor in every B-cell and an 
extremely large antibody repertoire. 
 
 
Both of these processes for generation 
of antibody diversity are essentially stochastic, 
resulting in the development of B-cells with 
antigen receptors that recognise self-antigens, in 
addition to B-cells producing antibodies against 
foreign antigens.  The former, if allowed to 
develop unchecked, can produce autoantibodies 
that attack the host’s own tissues, resulting in 
autoimmune disease.  Consequently, the 
immune system has to learn to discriminate 
between self and non-self.  This distinction is 
learned by encounter of developing B- and T-
cells with self-antigens during development, 
when self-reactive cells are either deleted or 
rendered unable to respond to self-antigen.[4] 
 
 To answer these questions, clusters of 
B-cells were excised from tissue sections of 
salivary gland biopsies by microdissection, and 
their expressed Ig V-genes cloned and 
sequenced.  Only rearranged Ig V-genes are 
expressed, and the rearrangement is unique in 
each cell, hence V-genes derived from the same 
clone of B-cells can be identified since they 
share the same V (D) and J exons and have the 
same sequence at the junctions.  Analysis of the 
rearranged V-gene sequences shows that an 
antigen driven, germinal centre-type B cell 
response is taking place within the salivary 
glands of Sjögren’s syndrome patients. 
 
The safeguards that ensure self/non-self 
discrimination fail to operate in some 
individuals, with the result that the immune 
system attacks and destroys their own tissues, 
causing autoimmune disease.  This can take 
many forms, each of which involves damage to 
a different organ or tissue, but the reasons why 
the immune system fails to recognise the tissue 
antigens as self are unknown.[5-7]  Structures 
resembling germinal centres are seen in the 
target tissues of several autoimmune diseases, 
including the salivary glands of patients with 
Sjögren’s syndrome[8;9].  
 
2.  MATERIALS AND METHODS 
 
2.1 Patients. 
  
Patient BW was a 65-year-old female with 
primary SS; Patient SG was a 39-year-old 
female with secondary SS and polychondritis.  
Minor lip salivary glands were removed 
surgically as part of the normal diagnostic 
procedure.  Immediately after removal, they 
were embedded in Tissue-Tek OCT embedding 
medium (Miles, Gieβen, Germany), frozen on 
cardice and stored at -70ºC.   
 
2.2  Immunohistochemical staining of 
tissue sections. 
 
6 or 8 µm sections were cut from the frozen 
salivary glands at -18°C on a cryomicrotome 
(Leitz).  The sections were mounted on slides 
and fixed in acetone.  The slides were stored at -
70ºC in the presence of  desiccant until required.  
Frozen sections were stained with mouse 
monoclonal antibodies specific for B cells (anti-
CD20, Dako), T cells (anti-CD3, Dako), 
follicular dendritic cells (Wue-2) and plasma 
cells  (Wue-1) (A. Greiner, University of 
Würzburg), followed by rabbit anti-mouse Ig 
(Dako) and the alkaline phosphatase-anti-
alkaline phosphatase (APAAP) complex (Dako).  
Immune complexes containing APAAP were 
detected by incubation with new fuchsin 
substrate (Dako) and the sections counter-
stained with Mayer’s haematoxylin (Sigma). 
 
2.3  Microdissection of cell clusters and 
preparation of DNA. 
 
Clusters of lymphoid cells were identified by 
staining with monoclonal antibodies as 
described above and excised with sterile blood 
lancets under sterile Scott’s tap water substitute 
(0.35% NaHCO3, 0.2% MgSO4) using an 
inverted microscope.  The excised tissue was 
digested in 20 µl proteinase K (0.7 mg/ml, 
Boehringer Mannheim) at 50ºC., 1h and the 
enzyme inactivated at 95ºC, 10 min.  
 
 
2.4  PCR amplification and cloning of 
rearranged Ig V-genes. 
 
The primers and methods used for amplification 
and cloning of rearranged Ig V-genes have 
already been described [17-19] and are 
summarised here.  All procedures prior to PCR 
took place in a separate laboratory from that 
where PCR amplification and all subsequent 
steps were performed, in order to avoid 
contamination of samples and reagents with 
amplified Ig V-genes.  Rearranged VH or VL 
genes were amplified from 10 µl of DNA 
extracted from the cell cluster by two stage 
PCR.  Two methods were used.  In the first 
method, a mixture of primers corresponding to 
the first framework region of each of the VH or 
VL gene families was used with primers for each 
of the JH or JL exons to ensure that all rearranged 
VH and VL-genes were amplified [20].   The 
product was purified by agarose gel 
electrophoresis and reamplified using  separate 
primers for each VH, Vκ or Vλ family.   
 
Alternatively, nested primers were 
used.  These corresponded to the leader 
sequence for each VH family and a universal JH 
primer [21].  0.5 µl of the first PCR product was 
subjected to a second PCR without prior 
purification, using the internal primers described 
above. Duplicate negative control samples 
containing water instead of DNA were always 
amplified in parallel with sample DNA.  These 
produced no detectable band after the second 
amplification.  Amplified DNA was purified by 
agarose gel electrophoresis, ligated into plasmid 
vector pCRII and cloned using the TA cloning 
system (Invitrogen).  
 
2.5  Sequencing and analysis of 
rearranged Ig V-genes. 
 
Cloned, rearranged Ig V-genes were sequenced 
from both ends by a modified Taq sequencing 
protocol using digoxigenin end-labelled primers 
(TIB Mol Biol, Berlin), or using an automatic 
DNA sequencer (Applied Biosystems), as 
previously described [22].  The best matching 
germline Ig V-genes were identified by 
searching the human VBase Sequence Directory 
(Tomlinson et al., M.R.C. Centre for Protein 
Engineering, Cambridge, U.K.).  Sequences 
were compared with the corresponding germline 
gene using the DNA Plot 1.4 programme (W. 
Müller, Institut für Genetik, Köln, Germany).  
Family trees based on V-gene sequences with 
identical V-D-J or V-J rearrangements were 
constructed by analysis of shared and unshared 
mutations. 
 
 
3.  RESULTS 
 
3.1  Germinal centre-like clusters of 
cells are present in SS salivary glands. 
 
Tightly packed clusters of  B-cells, T-cells and 
FDCs were identified in salivary glands of SS 
patients BW and SG by immunohistochemical 
staining.  Fig. 2 shows a large cluster of cells 
(SG-R) around a salivary duct in a lip salivary 
gland of patient SG.  Two patches of FDCs (Fig. 
2(c)) are surrounded by B-cells (Fig. 2(a)).  T-
cells are mainly localised to the upper left area 
of the cluster (Fig. 2(b)).  Many plasma cells are 
present in the area between two germinal centre-
like clusters (Fig. 2(d), SG-L and SG-R), but 
very few are present within the clusters, 
suggesting that they have arisen by 
differentiation of B-cells in the clusters and 
migrated out.  None of the cell clusters had a 
discernible mantle zone, normally found 
surrounding germinal centres in the spleen and 
lymph nodes.  Since the mantle zone is believed 
to originate from the cells of the primary follicle, 
due to the outward expansion of B-cells in the 
germinal centre, this implies that the cell clusters 
in the salivary glands did not develop within 
primary follicles.   
 
 
 
 
 
Figure 2. Germinal centre-like cluster SG-R in a 
lip salivary gland biopsy from patient SG.  (a) 
SG-R stained for B-cells with anti-CD20 (x100); 
(b) T-cells stained with anti-CD3 (x100; (c) 
FDCs (x400); (d) plasma cells between the two 
cell clusters SG-L and SG-R (x20).  Adapted 
from ref. [19] 
 
3.2 Ig V-gene expression in B-cell 
clusters. 
 
A cluster of B-cells, T-cells and FDCs was 
excised from a salivary gland of patient BW and 
27 rearranged Ig V-genes cloned and sequenced.  
Of these, five independent VH-D-J and two VL-J 
rearrangements were shared by two or more 
cloned genes containing base differences.  The 
number of base differences in 4 of these sets of 
V-genes was above the PCR error rate of  1 base 
per 1200 or approximately one base change per 
four VH-genes, determined by sequence analysis 
of rearranged germline V-genes and hybridomas 
[18], implying that they are derived from 
different members of the same B-cell clone.  
This is consistent with previous estimates of the 
PCR error rate [23-25].  Only one of these sets 
of V-genes (using germline gene DP-79) 
included sequences that could be ascribed to 
parental and daughter cells on the basis of shared 
mutations, suggesting that the parent cell had 
divided within the salivary gland (Fig. 3a).  Two 
pairs of rearranged V-genes differed from their 
partners by six and three bases respectively, and 
are therefore presumably from cells that have 
divided and mutated, but without the parental 
gene we do not have direct evidence that these 
events took place within the cell cluster where 
the cells were found. 
The majority of the rearranged VH-genes 
isolated from two cell clusters (SG-L & SG-R) 
in the salivary gland biopsy of a second patient 
(SG) shared two sets of V, D and J exons.  5/8 
of the VH-genes from SG-L used germline V-
gene VH328 with the D exon DXP’1 and JH5b; 
21/29 VH-genes from SG-R used germline V-
gene DP10 with D exon DA-1 and JH4b, 
respectively.  All genes using the same VH/D/J 
combination had identical junctional sequences 
and were therefore members of the same B-cell 
clone.  All of the 8 remaining VH-genes isolated 
from cluster SG-R used the germline gene DP65 
and were non-functional rearrangements 
containing stop codons but had different 
mutation patterns.  Since all functional VH-genes 
from this cluster were derived from the same 
clone of B-cells, it seems likely that the non-
functional DP-65 genes were also derived from 
this clone and had undergone somatic 
hypermutation during proliferation.  Similarly, 
all 11 Vλ genes isolated from cluster SG-R 
shared the same rearrangement of germline gene 
DPL16.  4 functional Vκ genes were isolated 
from this cluster; 2 of these shared the same 
germline gene (B3) and they contained few 
mutations (Table 1).   Thus, it would appear that 
the majority of cells in this cluster are members  
of the same clone. 
 
 
 
      
Mean R/S ± S.D. 
Section/ 
Cluster 
V-gene 
Family 
Germline 
V-gene 
No. of 
Sequences 
Isolated 
Av. No. of 
Mutations/ 
V-region 
Framework 
Region 
 
CDRs 
       
82 L VH3  V3-49  1    9 4.0 >4 
 VH4  DP-65  2  22 2.2 >6 
   VH328  5  26 ± 1.1 1.3 ± 0.13   2.3 ± 
0.38 
81 R VH1  DP-10  21  14.7 ± 1.2 1.2 ± 0.22   0.9 ± 
0.19 
 VH4  DP-65†*  8     
 Vκ1  L5  2    9 3.0   4.0 
 Vκ1  08/018†  1     
 Vκ4  B3  2    1.5 ± 0.5 >1 >0.5 
   B3†  1    
 Vκ5  B2†  1    
 Vλ3  DPL16  10    8.6 ± 1.1 1.2 ± 0.24 >4 ± 
0.6 
   DPL16†  1  10 1.0 >4 
       
 
Table 1.  Rearranged, mutated Ig V-genes from cell clusters L & R in a lip salivary gland biopsy of 
patient SG, identified by the best matching germline V-gene.  The number of sequences isolated is the 
number with different mutations sharing the same rearrangement.  Adapted from ref. [19] 
†Non-functional 
*Different rearrangement from DP-65 in cluster SG-L. 
 
Isolation of rearranged V-genes from 
a single B-cell clone could be due to selection 
bias during the PCR amplification.  That this 
has not occurred here is shown by the 
identification of multiple, independently 
rearranged V-genes from cluster BW, 
peripheral blood lymphocytes (data not 
shown), a pharyngeal tonsil germinal centre 
[26] and germinal centres in the thymus of a 
patient with myasthenia gravis[18] using the 
same protocol.  The pattern of V-gene usage in 
the latter case closely resembles the pattern in 
peripheral blood lymphocytes from a healthy 
individual obtained independently by other 
research groups [24;27], confirming that there 
is no selection bias.  Approximately 10,000 B-
cells were present in each section of clusters 
SG-L and SG-R so, if other B-cell clones were 
present in significant numbers we would 
expect to have detected them, although we 
cannot rule out the possibility that another 
clone(s) might be present in other regions of 
the cell cluster.  None of the VH-D-J 
rearrangements was present in the cells of the 
neighbouring cluster, showing that B-cells had 
not migrated between the two clusters. 
 
3.3 Somatic hypermutation of Ig V-
genes in SS salivary glands. 
 
Most of the V-genes cloned from cluster BW 
contained relatively few mutations, including 
the clonally related DP79(a) set.  In contrast, 
all members of the two clonally related sets of 
V-genes  from patient SG were hypermutated; 
range 13 - 20 mutations per VH-gene in SG-R; 
24 - 27 mutations per VH-gene in SG-L; and an 
average of 8.6 +/- 1.1 mutations in the Vλ gene 
set from cluster SG-R (Table 1).  In clusters 
SG-L and SG-R, we see a stepwise 
accumulation of mutations in VH  and Vλ genes 
enabling us to draw genealogical trees arising 
from the original naïve B-cell expressing the 
unmutated germline gene (Fig. 3).  This clearly 
demonstrates that the two clones developed 
within the salivary gland by proliferation of a 
common precursor accompanied by V-gene 
diversification through somatic hypermutation. 
 
3.4 Proliferation of B-cells in the 
salivary glands is antigen-driven. 
 
 
4.  DISCUSSION  
 After clonal proliferation and somatic 
hypermutation, the second phase of the 
germinal centre response to a xenoantigen is 
selection of B-cells expressing high affinity 
receptors by a second encounter with antigen 
on the surface of FDCs.  Deviation from 
random of the ratio of replacement to silent 
mutations (R:S) in the CDR and framework 
regions are regarded as evidence for antigen 
selection [28], although it is now accepted that 
there is also an inherent bias towards a high 
R:S ratio in the CDRs and a low R:S ratio in 
the framework regions as a result of a bias in 
the hypermutation mechanism towards certain 
base sequences, such as the RGYW motif [29].  
Interestingly, all of the VH-genes that were 
members of B-cell clones in the B-cell clusters 
from SS salivary glands had significantly 
lower than expected R:S ratios in both their 
CDRs and framework regions.  This is against 
the natural bias and is clear evidence for 
selection against replacement mutations. 
Sjögren’s syndrome is an inflammatory 
autoimmune disease of the mucosal tissues 
affecting the salivary glands, lachrymal glands 
and mucosal tissues of the intestine.  Focal 
infiltrates of B- and T-lymphocytes develop 
around the ducts; some of these foci develop 
into large clusters containing many B- and T-
cells.  Plasma cells are also visible in the 
surrounding glandular tissue, as shown here.  
We have now demonstrated that these large 
clusters of lymphocytes contain FDCs and 
have internal structure similar to that of a 
germinal centre, viz. segregation of areas 
containing B-cells, FDCs and T-cells.  So far 
as we are aware, we are the first to 
demonstrate the presence of FDCs in the 
salivary glands of SS patients.  The much 
smaller cluster in the salivary gland of patient 
BW did not show this segregation, all three 
cell types being distributed throughout the cell 
cluster; this may represent an earlier stage of 
germinal centre formation, an hypothesis 
supported by the presence of smaller, less 
mutated B-cell clones.   
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In order to determine whether a 
germinal centre-type reaction is taking place 
within these foci, we excised them by 
microdissection and cloned and sequenced the 
rearranged Ig V-genes, encoding antigen 
receptors, from B-cells within the clusters.  
The small cell cluster BW was polyclonal with 
many of the rearranged V-genes containing 
few or no mutations.  One group of four VH-
genes all had identical rearrangements but only 
low numbers of base differences from the 
germline gene, albeit above the PCR error rate, 
suggesting that they were derived from B-cells 
that had divided within cluster BW.  
 
 
Figure 3.  Genealogical trees of B-cell clones 
in clusters BW, SG-L and SG-R, identified by 
their rearranged, mutated Ig V-genes.  The 
members of each clone share identical 
sequences at the V-D-J or V-J junction.  (a) A 
B-cell clone in cluster BW expressing mutants 
of germline gene DP79;  (b) A B-cell clone 
using germline gene VH328 from cluster SG-L; 
(c) and (d) B-cell clones using germline genes 
VH DP-10 and VL DPL16 from cluster SG-R.  
The top circle in each set represents the naïve 
B-cell expressing the unmutated germline 
gene.  Numbers inside other circles are 
arbitrary numbers designating cloned genes.  
Numbers at the sides of the arrows indicate the 
minimum number of point mutations to 
generate a daughter cell.  Dashed circles 
represent hypothetical intermediates.  Adapted 
from ref. [19]. 
 
 The two large cell clusters from 
patient SG resemble fully developed germinal 
centres since all except one of the functionally 
rearranged VH-genes were derived from two 
clones of B-cells, one in each cell cluster. The 
observation of large numbers of plasma cells 
surrounding these clusters also supports this 
hypothesis.  Both B-cell clones in clusters SG-
R and L contained a large number of mutations 
compared with the corresponding germline 
genes.  Each of the two clones proliferated 
within the clusters from common precursor 
cells since a genealogical tree can be drawn for 
each on the basis of shared and unshared 
mutations (Fig. 3).  
 
Despite the high frequency of 
mutation, indicative of a memory response, the 
low R:S ratios of mutations in the framework 
regions and CDRs of VH328 and DP-10 
indicate that selection against replacement 
mutations has occurred. Low R:S ratios were 
also found in the CDRs of hypermutated 
rheumatoid factors from healthy donors [30], 
antibodies produced by germinal centre B-cells 
in synovial membranes from rheumatoid 
arthritis patients [17] and anti-DNA antibodies 
from SLE patients [31].  These results imply 
that antigen selection is driving the B-cell 
response within the salivary gland in SS and in 
the synovial membrane in rheumatoid arthritis.  
These results contrast with the high R:S ratio 
in the CDRs of antibodies against most 
xenogeneic antigens, suggesting that different 
selection processes may operate during the 
autoimmune response. 
 
Lower than random R:S ratios in the 
CDRs during an autoimmune response could 
be due to the presence of high concentrations 
of autoantigen within the target tissue.  B-cells 
expressing high affinity antigen receptors 
would have no selective advantage over cells 
expressing receptors with lower affinity.  
Negative selection would still be effective, 
however, since mutations that remove contact 
residues or disrupt the V-domain structure 
would render the antigen receptor unable to 
bind antigen and/or unable to signal to the B-
cell, consequently, the cell would cease to 
divide.  This is consistent with the antigen 
mimicry hypothesis, in which a pathogenic 
microorganism triggers a small number of B-
cells with cross-reactive receptors for a self-
antigen (e.g. SS-A).  The response would be 
maintained by high concentrations of self-
antigen presented on follicular dendritic cells 
in the salivary glands.  Intra- and 
intermolecular epitope spreading would then 
lead to production of other autoantibodies, e.g. 
against SS-B and rheumatoid factor.   
 
The origin of the parental B-cells that 
founded the clones proliferating within the cell 
clusters in the salivary glands is not known, 
but the low number of mutations in the DP79 
clone found in cluster BW suggests that this 
clone arose from a naïve B-cell, whereas the 
clones in SG-L and SG-R, which were more 
heavily mutated, probably arose from memory 
B-cells. This is consistent with a chronic 
autoimmune response with continual 
restimulation by self-antigen.  The memory B-
cells may either be generated in a secondary 
lymphoid organ and subsequently migrate to 
the salivary gland, or they may develop in the 
salivary gland itself, where they become 
activated and induced to proliferate.  Our data 
show that a microenvironment is built up 
 within the salivary gland that allows a 
germinal centre reaction to take place.   
 
 Ectopic germinal centre-like 
structures have been described in other 
autoimmune diseases, including Hashimoto’s 
thyroiditis, autoimmune hepatitis, autoimmune 
uveoretinitis and cryptogenic fibrosing 
alveolitis, on the basis of their 
immunochemical staining [32-35], although 
evidence of a germinal centre reaction, as 
described here, has not yet been presented in 
these cases.  We have demonstrated that 
germinal centre reactions, i.e. antigen-driven 
clonal proliferation of B-cells, somatic 
hypermutation of their Ig V-genes and antigen 
selection, occur in the salivary glands of 
Sjögren’s syndrome patients.  A similar 
response has also been described in the 
synovial membranes of rheumatoid and 
reactive arthritis patients [17;26;36;37] and in 
germinal centres in the thymus of myasthenia 
gravis patients [18].  The combination of 
histological and molecular evidence suggest 
that germinal centre-type reactions in the 
target tissue may be a common feature of 
autoimmune diseases.  The knowledge that 
ectopic germinal centres in the target tissues 
are a site of local antigen stimulation in 
autoimmune disease implies that these could 
be a target for therapeutic intervention.  Recent 
clinical trials, in which a monoclonal antibody 
that blocks the germinal centre response was 
administered to SLE patients, are a promising 
move in this direction (Lipsky, P.,  
International Congress of Immunology, 
Stockholm, 2001).   
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